People · Operator
Named in public records as an officer, director or promoter · active 2017–2023 · Pharmaceuticals, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| S1P Therapeutics Inc. | — | Pharmaceuticals | Seed | $2.0M | $16.9M | 2023 |
| Continuum Biosciences, Inc. | — | Biotech / Pharma | Pre-Seed | $500K | $25.6M | 2017 |
Webster Santos at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Webster Santos on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Lynch | 1 | 4 |
| Alexander Tristan Edwards | 1 | 4 |
| David Tristan Sinclair | 1 | 3 |
| JOHN AMATRUDA | 1 | 2 |
| Ronald Sayco | 1 | 1 |
| Kyle Hoehn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.